[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fIB0JJdpPuezZZT_-MX3kxSK6tnzfI4Kv6e3Dyr6_p4s":3},{"_id":4,"category":5,"content":9,"date":10,"heroImage":9,"newsPageBuilder":11,"seo":9,"slug":59,"title":60},"169b176d-5255-46a7-9c7c-a805e8837ef7",{"_id":6,"slug":7,"title":8},"d5f23208-d5ad-4b48-a510-a5616e101bb2","general","General",null,"2024-02-28T00:00:00.000Z",[12],{"_key":13,"_type":14,"content":15},"nc5","newsContent",[16,27,35,43,51],{"_key":17,"_type":18,"children":19,"markDefs":25,"style":26},"b5p1","block",[20],{"_key":21,"_type":22,"marks":23,"text":24},"s5p1","span",[],"KLISBio, a regenerative medicine company utilizing silk-based technology, has received a €2.5 million grant from the EIC Accelerator Program administered by the European Innovation Council and SMEs Executive Agency (EISMEA). The funding represents non-dilutive capital and provides potential access to additional equity matching facilities.",[],"normal",{"_key":28,"_type":18,"children":29,"markDefs":34,"style":26},"b5p2",[30],{"_key":31,"_type":22,"marks":32,"text":33},"s5p2",[],"The company is advancing several medical devices, including SILKBridge Nerve Guide for peripheral nerve repair, along with applications in rotator cuff repair, bone grafting, and vascular grafting. CEO Gabriele Grecchi expressed enthusiasm about the award, stating: \"This milestone validates the dedication and innovation that KLISBio brings to regenerative medicine.\"",[],{"_key":36,"_type":18,"children":37,"markDefs":42,"style":26},"b5p3",[38],{"_key":39,"_type":22,"marks":40,"text":41},"s5p3",[],"CTO and Founder Antonio Alessandrino characterized the recognition as a collective achievement, acknowledging the team's contributions throughout the startup journey.",[],{"_key":44,"_type":18,"children":45,"markDefs":50,"style":26},"b5p4",[46],{"_key":47,"_type":22,"marks":48,"text":49},"s5p4",[],"KLISBio holds multiple patents covering silk-based technologies and is led by experienced medtech professionals. The leadership includes Grecchi as CEO, Alessandrino as Chief Technology Officer, Giuliano Freddi as Chief Scientific Officer, and Rodrigo Bianchi serving as Board Chairman with over thirty years of healthcare industry experience.",[],{"_key":52,"_type":18,"children":53,"markDefs":58,"style":26},"b5p5",[54],{"_key":55,"_type":22,"marks":56,"text":57},"s5p5",[],"The company collaborates with physicians, engineers, researchers, chemists, and biologists globally to advance regenerative medicine solutions.",[],"klisbio-secures-euro25-million-grant-eic-accelerator-program-propel-growth-europe","KLISBio Secures €2.5 Million Grant by the EIC Accelerator Program to Propel Growth in Europe"]